中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

117 records (took 0.032 seconds)

    Recovery System for UAV
    103.
    发明申请
    Recovery System for UAV 审中-公开

    公开(公告)号：US20200148387A1

    公开(公告)日：2020-05-14

    申请号：US16604436

    申请日：2018-04-12

    Applicant: Norwegian University of Science and Technology (NTNU)

    Inventor： Tor Arne JOHANSEN ,  Thor Inge FOSSEN ,  Kristian KLAUSEN

    IPC: B64F1/02 ,  B64C39/02

    Abstract: An unmanned airborne vehicle (UAV) recovery system for in-flight recovery of a fixed wing UAV includes a catching device and a plurality of hover-capable drones, such as multi-rotors. The catching device is for catching the fixed wing UAV via a hook system during flight of the fixed wing UAV and takes the form of a line between the recovery drones. The recovery drones are arranged to support the catching device as it spans a gap in a horizontal orientation with the catching device suspended between at least two recovery drones that are in flight and spaced apart horizontally from each other either side of the gap. During a recovery operation the recovery drones co-ordinate their movement to adopt a flight path relative to a flight path of the fixed wing UAV to define a virtual runway for interception of the fixed wing UAV by the recovery system.

    ANTIMICROBIAL AGENTS AND THEIR USE IN THERAPY
    104.
    发明申请
    ANTIMICROBIAL AGENTS AND THEIR USE IN THERAPY 审中-公开

    公开(公告)号：US20200095286A1

    公开(公告)日：2020-03-26

    申请号：US16592462

    申请日：2019-10-03

    Applicant: Norwegian University of Science and Technology

    Inventor： Marit Otterlei ,  Siri Bachke

    IPC: C07K14/00 ,  A61K38/17 ,  A01N25/08 ,  A61K31/165 ,  A61K31/35 ,  A61K31/397 ,  A61K31/43 ,  A61K31/496 ,  A61K31/7036 ,  A61K31/7048 ,  A61K38/14 ,  A61K38/16 ,  A61K41/00 ,  A61K45/06 ,  A61L2/10 ,  A61L2/16

    Abstract: The present invention provides an agent, or a composition containing an agent, for use in treating or preventing a bacterial infection in a subject, wherein said agent comprises: (i) an oligopeptidic compound comprising a PCNA interacting motif and a domain that facilitates the cellular uptake of said compound, wherein the PCNA interacting motif is X1X2X3X4X5 (SEQ ID NO: 1) and wherein: X1 is a basic amino acid; X2 is an aromatic amino acid; X3 is an uncharged amino acid other than an aromatic amino acid, Glycine (G) and Proline (P); X4 is any amino acid other than Proline (P), an acidic amino acid or an aromatic amino acid; and X5 is a basic amino acid or Proline (P); or (ii) a nucleic acid molecule comprising a sequence encoding the oligopeptidic compound of (i). In certain aspects the agent and compositions of the invention may be used as single agents. In other aspects of the invention agents and compositions of the invention may be used in conjunction with one or more additional active agents, such as antibiotics.

    Anti-bacterial agents and their use in therapy
    106.
    发明授权
    Anti-bacterial agents and their use in therapy 有权

    公开(公告)号：US10570180B2

    公开(公告)日：2020-02-25

    申请号：US15570837

    申请日：2016-05-06

    Applicant: Norwegian University of Science and Technology (NTNU)

    Inventor： Marit Otterlei ,  Siri Bachke

    IPC: A01N37/18 ,  A61K38/00 ,  A61P31/04 ,  A61K38/08 ,  A61K38/04 ,  C07K5/00 ,  C07K7/00 ,  C07K16/00 ,  C07K17/00 ,  C07K14/00 ,  A61K38/17 ,  C07K14/47 ,  A61K47/50 ,  A61L9/20 ,  A61L27/22 ,  C12N5/078

    Abstract: The present invention provides an agent, or a composition containing an agent, for use in treating or preventing a bacterial infection in a subject, wherein said agent comprises: (i) an oligopeptidic compound comprising a PCNA interacting motif and a domain that facilitates the cellular uptake of said compound, wherein the PCNA interacting motif is X1X2X3X4X5X6 (SEQ ID NO: 1) and wherein: X1 is a basic amino acid; X2 is an aromatic amino acid; X3 is an aromatic amino acid or a hydrophobic amino acid that has an R group comprising at least three carbon atoms; X4 is an uncharged amino acid other than an aromatic amino acid, Glycine (G) and Proline (P); X5 is any amino acid other than an acidic amino acid or an aromatic amino acid; and X6 is any amino acid other than an acidic amino acid or an aromatic amino acid, preferably a basic amino acid or Proline (P), wherein when X3 is not an aromatic amino acid, X5 is not lysine (K) and X6 is a basic amino acid or Proline (P); or (ii) a nucleic acid molecule comprising a sequence encoding the oligopeptidic compound of (i). In certain aspects the agent and composition of the invention may be used as single agents. In other aspects of the invention the agents and composition may be used in conjunction with one or more addition active agents, such as antibiotics, or in combination with UV radiation.

    Solar cells
    108.
    发明授权
    Solar cells 有权

    公开(公告)号：US10347781B2

    公开(公告)日：2019-07-09

    申请号：US14409837

    申请日：2013-06-21

    Applicant: NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NTNU)

    Inventor： Helge Weman ,  Bjørn-Ove Fimland ,  Dong Chul Kim

    IPC: H01L31/18 ,  H01L31/0224 ,  H01L31/0304 ,  H01L31/0352

    Abstract: A composition of matter, in particular a photovoltaic cell, comprising: at least one core semiconductor nanowire on a graphitic substrate, said at least one core nanowire having been grown epitaxially on said substrate wherein said nanowire comprises at least one group III-V compound or at least one group II-VI compound or at least one group IV element; a semiconductor shell surrounding said core nanowire, said shell comprising at least one group III-V compound or at least one group II-VI compound or at least one group IV element such that said core nanowire and said shell form a n-type semiconductor and a p-type semiconductor respectively or vice versa; and an outer conducting coating surrounding said shell which forms an electrode contact.

Patent Agency Ranking